# Cathera, Inc.

- Location (FDA's records): Mountain View, CA
- FDA decisions: 2 (2015–2018): 2 510(k) clearances
- Product codes: DQY (2)
- Predicates its devices cite: 5 (1 its own); citations of its devices by later devices: 5 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Cordis Neurovascular, Inc.: 2 (https://510kreport.com/company/cordis-neurovascular)
- Chestnut Medical Technologies, Inc.: 1 (https://510kreport.com/company/chestnut-medical-technologies)
- Target Therapeutics: 1 (https://510kreport.com/company/target-therapeutics)

## Firms that cite its devices most
- Micro Therapeutics Lnc. D/B/A Ev3 Neurovascular: 2 (https://510kreport.com/company/micro-therapeutics-lnc-d-b-a-ev3-neurovascular)
- Hexacath: 1 (https://510kreport.com/company/hexacath)
- Spartan Micro, Inc.: 1 (https://510kreport.com/company/spartan-micro)

## Its most-cited devices
- K151638: Phenom 17 Catheter, Phenom 21 Catheter, Phenom 27 Catheter, Phenom Plus Catheter (2015), cited by 3
- K180959: Phenom 27 Catheter (2018), cited by 2

## Recent decisions
- K180959: Phenom 27 Catheter (Jun 11, 2018)
- K151638: Phenom 17 Catheter, Phenom 21 Catheter, Phenom 27 Catheter, Phenom Plus Catheter (Nov 13, 2015)

Source page: https://510kreport.com/company/cathera